Nymox Pharmaceutical
NYMX
#9940
Rank
โ‚ฌ17.5 M
Marketcap
Country
0,19ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.11 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ6.26 Million, an increase over its 2021 earnings that were of -โ‚ฌ11.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.11 Million-66.35%
2022 -โ‚ฌ6.26 Million-47.71%
2021 -โ‚ฌ11.98 Million6.61%
2020 -โ‚ฌ11.23 Million-10.91%
2019 -โ‚ฌ12.61 Million24.24%
2018 -โ‚ฌ10.15 Million-20.03%
2017 -โ‚ฌ12.69 Million2.71%
2016 -โ‚ฌ12.36 Million-63.86%
2015 -โ‚ฌ34.18 Million674.44%
2014 -โ‚ฌ4.42 Million-6.11%
2013 -โ‚ฌ4.71 Million-35.66%
2012 -โ‚ฌ7.31 Million-20.76%
2011 -โ‚ฌ9.23 Million38.33%
2010 -โ‚ฌ6.67 Million35.59%
2009 -โ‚ฌ4.92 Million11.8%
2008 -โ‚ฌ4.4 Million-12.94%
2007 -โ‚ฌ5.06 Million8.85%
2006 -โ‚ฌ4.64 Million36.5%
2005 -โ‚ฌ3.4 Million-4.4%
2004 -โ‚ฌ3.56 Million-14.58%
2003 -โ‚ฌ4.17 Million
2001 -โ‚ฌ3.06 Million-20.54%
2000 -โ‚ฌ3.85 Million21.72%
1999 -โ‚ฌ3.16 Million-25.56%
1998 -โ‚ฌ4.25 Million101.3%
1997 -โ‚ฌ2.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.50 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.65 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.06 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.73 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.73 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA